A study to investigate OCB-030

Trial Profile

A study to investigate OCB-030

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2015

At a glance

  • Drugs OCB 030 (Primary)
  • Indications Hepatitis B; Hepatitis C
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Aug 2015 New trial record
    • 05 Aug 2015 According to an Arbutus Biopharma media release, the company expects to file an IND for OCB-030 in the fourth quarter of 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top